AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects | Anemia, Hypochromic, Hemic and Lymphatic Diseases, Iron Deficiencies, Nutritional and Metabolic Diseases, anemia, hematologic disorder, iron deficiency anemia, iron metabolism disease, metabolic disease | Recruiting | Phase 3 | 2026-04-17 | NCT03893045 | |
| A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) | Anemia, Hypochromic, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Iron Deficiencies, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, anemia, chronic renal failure syndrome, hematologic disorder, iron deficiency anemia, iron metabolism disease, kidney disorder, kidney failure, metabolic disease, urinary system disorder | Recruiting | Phase 3 | 2026-04-17 | NCT03619850 | |
| Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient | Anemia, Hypochromic, Hemic and Lymphatic Diseases, Iron Deficiencies, Nutritional and Metabolic Diseases, anemia, hematologic disorder, iron deficiency anemia, iron metabolism disease, metabolic disease | Recruiting | Phase 3 | 2025-10-03 | NCT04268849 |